Dr Ezekiel E Warbah., MD (HOM), BHMS
ABSTRACT
Background: Tinea corporis is a common superficial dermatophyte infection affecting the glabrous skin and is predominantly caused by species of Trichophyton, Microsporum, and Epidermophyton. The rising incidence of recurrent and treatment-resistant dermatophytosis, particularly in tropical and subtropical regions, has highlighted the need to explore complementary therapeutic approaches. Homoeopathy offers an individualized therapeutic approach; however, clinical evidence evaluating specific homoeopathic medicines in the management of Tinea corporis remains limited.
Objective: To clinically evaluate the homoeopathic medicine Chrysarobinum 30C in the management of Tinea corporis using the Dermatology Life Quality Index (DLQI).
Materials and Methods: A prospective observational study was conducted on 40 patients diagnosed with Tinea corporis who fulfilled the inclusion and exclusion criteria after obtaining informed consent. Diagnosis was established based on clinical history, physical examination,and skin inspection. A Standardised Case Record (SCR) was used to document detailed case information. Participants received Chrysarobinum 30C (four medicated globules, three times daily) for two weeks. Dermatology-related quality of life was assessed before and after treatment using the Dermatology Life Quality Index (DLQI). Statistical analysis was performed using the paired t-test.
Results: Forty patients completed the study. The groin was the most frequently affected site (32.5%). Clinical improvement was observed in 90% of participants following treatment. A statistically significant reduction in Dermatology Life Quality Index (DLQI) scores was observed, with the mean DLQI score decreasing from 8.425 ± 2.89 before treatment to 5.975 ± 2.24 after treatment (p < 0.001).
Conclusion: The findings of this prospective observational study suggest that treatment with the Homoeopathic medicine Chrysarobinum 30C was associated with improvement in dermatology-related quality of life among patients with Tinea corporis. Further controlled clinical studies with larger sample sizes are warranted to validate these findings and further evaluate the role of Chrysarobinum 30C in the management of Tinea corporis.
Keywords: Tinea corporis; Dermatophytosis; Homoeopathy; Chrysarobinum 30C; Dermatology Life Quality Index (DLQI); Observational study; Quality of life.
Dr. Ezekiel E. Warbah., MD (HOM), BHMS
Department of Materia Medica, Father Muller Homoeopathic Medical College & Hospital,
Mangaluru, Karnataka, India
Research conducted during postgraduate training
Email: ezekielew13@gmail.com
Be the first to comment